 |
 |

Scintiscanning With Gallium Citrate 67Diagnosis of Head and Neck Malignant Neoplasms
Alan D. Kornblut, MD;
Edward B. Silberstein, MD;
Eugene L. Saenger, MD;
Donald A. Shumrick, MD
Arch Otolaryngol. 1974;100(3):201-205.
Abstract
Gallium citrate 67 scintigraphy was employed as a means for tumor diagnosis in 55 patients with suspected new or known previous history of squamous cell carcinoma involving the head and neck and in 23 patients with systemic lymphoreticular malignant neoplasm. In 34 of 55 (61.9%) patients with head and neck neoplasia and 20 of 23 (86.9%) patients with lymphoreticular malignant neoplasms, results of scintiscans correlated with clinical status. However, further study is required before routine use of the isotope can be applied to clinical study of tumors that involve the head or neck.
Author Affiliations
From the Department of Otolaryngology and Maxillofacial Surgery (Drs. Kornblut and Shumrick) and the Radioisotope Laboratory and Department of Medicine (Drs. Silberstein and Saenger), University of Cincinnati Medical Center and Cincinnati Veterans Administration Hospital, Cincinnati. Dr. Kornblut is now with the National Naval Medical Center, Bethesda, Md.
Footnotes
Accepted for publication Jan 9, 1974.
Reprint requests to Department of Otolaryngology, National Naval Medical Center, Bethesda, MD 20014 (Alan D. Kornblut, LCDR MC USNR).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|